Director at FibroBiologics (FBLG) receives 30,803 new stock options
Rhea-AI Filing Summary
FibroBiologics, Inc. director Matthew Link received a grant of stock options covering 30,803 shares of common stock. The options have an exercise price of $0.7503 per share and expire on June 22, 2036. Following this grant, he holds options for 30,803 shares directly. The options vest in full on the earlier of the first anniversary of the grant date or the company’s next annual meeting.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Link Matthew
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 30,803 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 30,803 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 30,803 options
Exercise price: $0.7503 per share
Expiration date: June 22, 2036
+2 more
5 metrics
Option grant size
30,803 options
Stock Option (Right to Buy) granted to director Matthew Link
Exercise price
$0.7503 per share
Exercise price of stock options on FibroBiologics common stock
Expiration date
June 22, 2036
Option expiration date for the granted stock options
Underlying shares
30,803 shares
Common stock underlying the granted options
Total options after grant
30,803 options
Total derivative securities held following this transaction
Key Terms
Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, vesting
4 terms
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
exercise price financial
"conversion_or_exercise_price: "0.7503""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The options will vest in full upon the earlier of the first anniversary of the date of grant or the date of the next annual meeting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did FibroBiologics (FBLG) report for Matthew Link?
FibroBiologics reported that director Matthew Link received a grant of stock options for 30,803 shares of common stock. These options were awarded as compensation, not purchased in the open market, and give him the right to buy shares at a fixed exercise price.
What is the exercise price and expiration date of Matthew Link’s FibroBiologics options?
Matthew Link’s stock options have an exercise price of $0.7503 per share and expire on June 22, 2036. This means he can buy up to 30,803 shares at that fixed price any time before the expiration, subject to vesting conditions.
When do Matthew Link’s FibroBiologics (FBLG) stock options vest?
The options vest in full upon the earlier of the first anniversary of the grant date or the date of the next annual shareholder meeting. This time-based vesting schedule means he must remain in his role until one of those milestones for the options to fully vest.